Brain damage caused by oxygen deficiency at birth is one of the main causes of death in newborns worldwide. Using a small animal model, researchers from the University Hospital Bonn (UKB) and DZNE tested treatment with 25 different active agents.
Setting up trials in APAC and Middle East can boost patient recruitment
Share this article The country’s import laws and regional political instability can impact product availability for clinical trials, said Carine Cochereau. Image Credit: Phalguni Deswal